Diagnostic Performance of BUU-Customized Whole-Exome Sequencing for Suspicious Thyroid Nodules: A Prospective Diagnostic Accuracy Study
Journal of Otolaryngology - Head & Neck Surgery · 2026-10 · 55
DOI: 10.1177/19160216261494119 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Otolaryngology - Head & Neck Surgery, online erschienen am 03.11.2026. Verfasst von Narit Jianbunjongkit und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Faculty of Medicine, Burapha University, Chonburi, Thailand. Hauptthemen laut MEDLINE: Thyroid Nodule, Exome Sequencing. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Importance: Suspicious thyroid nodules often prompt avoidable surgeries due to diagnostic uncertainty. Although commercial next-generation sequencing assays improve risk stratification, evidence for locally developed sequencing pipelines remains limited.
Objective
To evaluate the diagnostic performance of Burapha University-customized whole-exome sequencing (BUU-WES) using preoperative ultrasound-guided core needle biopsy (CNB) specimens, with postsurgical histopathology as the reference standard.
Design
Multicenter prospective diagnostic accuracy study.
Setting
Four tertiary-care hospitals in Thailand.
Participants
Adults (≥20 years) undergoing thyroid surgery for nodules suspicious on ultrasonography (American College of Radiology Thyroid Imaging Reporting and Data System 4-5) and/or cytology (Bethesda I-V).
Intervention
DNA extracted from CNB specimens underwent BUU-WES; variants were interpreted using curated databases and published evidence. Main Outcome and Measures: Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and overall accuracy with 95% confidence intervals (CIs).
Results
Among 82 participants (82 index nodules), malignancy prevalence was 25.6% (21/82). BUU-WES demonstrated sensitivity of 57.1% (95% CI, 34.0%-78.2%), specificity of 86.9% (95% CI, 75.8%-94.2%), PPV of 60.0% (95% CI, 36.1%-80.9%), and NPV of 85.5% (95% CI, 74.2%-93.1%). In nodules ≥1 cm (n = 71), sensitivity increased to 83.3% (95% CI, 51.6%-97.9%), specificity 89.8% (79.2%-96.2%), with NPV 96.4% (95% CI, 87.5%-99.6%). In indeterminate cytology (Bethesda III/IV), BUU-WES showed moderate diagnostic performance, with sensitivity of 60% and specificity and NPV of 86.4%. The most frequently detected alterations involved BRAF , NRAS , and KRAS .
Conclusions
BUU-WES primarily functions as a rule-in test due to its high specificity. Its most clinically relevant application is in indeterminate thyroid nodules (Bethesda III/IV), where it serves as an adjunctive tool for risk stratification. Within this subgroup, diagnostic performance is further optimized in nodules ≥1 cm, where the improved NPV suggests potential rule-out applicability in appropriately selected patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Faculty of Medicine, Burapha University, Chonburi, Thailand.
- The Center for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Thailand.
- Department of Pharmacology and Biopharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Burapha University, Chonburi, Thailand.
- Department of Radiology, Faculty of Medicine, Burapha University, Chonburi, Thailand.
- Department of Surgery, Queen Savang Vadhana Memorial Hospital, Chonburi, Thailand.
- Department of Otorhinolaryngology, Faculty of Medicine, Khon Kaen University, Thailand.
ORCID-Profile: Narit Jianbunjongkit, Apinya Jusakul, Alisara Wongsuttilert, Pattaravadee Srikoon
Zitieren
APA
Jianbunjongkit, N., Jusakul, A., Suksri, K., Wongsuttilert, A., Amornpinyokiat, N., Teeramatwanich, W., Kasemsrithanawat, K., & Srikoon, P. (2026). Diagnostic Performance of BUU-Customized Whole-Exome Sequencing for Suspicious Thyroid Nodules: A Prospective Diagnostic Accuracy Study. Journal of Otolaryngology - Head & Neck Surgery, 55. https://doi.org/10.1177/19160216261494119
Vancouver
Jianbunjongkit N, Jusakul A, Suksri K, Wongsuttilert A, Amornpinyokiat N, Teeramatwanich W, et al. Diagnostic Performance of BUU-Customized Whole-Exome Sequencing for Suspicious Thyroid Nodules: A Prospective Diagnostic Accuracy Study. Journal of Otolaryngology - Head & Neck Surgery. 2026;55. doi:10.1177/19160216261494119
BibTeX
@article{Jianbunjongkit2026,
author = {Jianbunjongkit, Narit and Jusakul, Apinya and Suksri, Kanchana and Wongsuttilert, Alisara and Amornpinyokiat, Nattawut and Teeramatwanich, Watchareporn and Kasemsrithanawat, Krongchai and Srikoon, Pattaravadee},
title = {Diagnostic Performance of BUU-Customized Whole-Exome Sequencing for Suspicious Thyroid Nodules: A Prospective Diagnostic Accuracy Study},
journal = {Journal of Otolaryngology - Head & Neck Surgery},
year = {2026},
volume = {55},
doi = {10.1177/19160216261494119}
}
EUVIMED